Fort Sheridan Advisors LLC Eli Lilly & CO Transaction History

Fort Sheridan Advisors LLC

$646 Million
Q1 2025

A detailed history of Fort Sheridan Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fort Sheridan Advisors LLC holds 4,872 shares of LLY stock, worth $3.77 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

4,872

Previous 4,890 0.37%

Holding current value

$3.77 Million

Previous $3.78 Million 6.57%

% of portfolio

0.62%

Previous 0.56%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$725.72 - $929.72 $13,062 - $16,734	-18 Reduced 0.37%	4,872 $4.02 Million
Q4 2024 Feb 05, 2025	BUY	$727.2 - $932.06 $34,905 - $44,738	48 Added 0.99%	4,890 $3.78 Million
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $20,075 - $24,960	-26 Reduced 0.53%	4,842 $4.29 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $13,772 - $17,271	-19 Reduced 0.39%	4,868 $4.41 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $132,652 - $177,470	-224 Reduced 4.38%	4,887 $3.8 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $34,776 - $47,944	-80 Reduced 1.54%	5,111 $2.75 Million
Q2 2023 Aug 01, 2023	BUY	$350.74 - $468.98 $783,553 - $1.05 Million	2,234 Added 75.55%	5,191 $2.43 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $269,316 - $316,298	867 Added 41.48%	2,957 $1.02 Million
Q4 2022 Feb 15, 2023	SELL	$321.55 - $374.67 $2,250 - $2,622	-7 Reduced 0.33%	2,090 $764,000
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $59,592 - $67,911	-201 Reduced 8.75%	2,097 $678,000
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $48,220 - $56,617	173 Added 8.14%	2,298 $745,000
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $7,744 - $9,624	33 Added 1.58%	2,125 $609,000
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $69,703 - $86,502	310 Added 17.4%	2,092 $578,000
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $5,983 - $7,363	-27 Reduced 1.49%	1,782 $412,000
Q2 2021 Aug 17, 2021	SELL	$180.55 - $233.54 $7,763 - $10,042	-43 Reduced 2.32%	1,809 $415,000
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $24,648 - $31,908	150 Added 8.81%	1,852 $346,000
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $52,053 - $68,879	-399 Reduced 18.99%	1,702 $287,000
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $307,208 - $355,342	2,101 New	2,101 $311,000

Others Institutions Holding LLY

# of Institutions

4,398

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $734B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Sheridan Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Sheridan Advisors LLC with notifications on news.

Account

Fort Sheridan Advisors LLC Eli Lilly & CO Transaction History